Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06465316 · RECRUITING
Trial details
- NCT number
- NCT06465316
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2026-12-31
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.